| P50 | author | Saeid Amini-Nik | Q38590197 |
| P2093 | author name string | Marc G Jeschke | |
| | Anna I Arno | |
| | Elaine Herer | |
| | Cassandra Belo | |
| | Mohammed Al-Shehab | |
| | Patrick H Blit | |
| P2860 | cites work | Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies | Q24595036 |
| | Prevention and treatment of excessive dermal scarring | Q24650485 |
| | Scar-free healing: from embryonic mechanisms to adult therapeutic intervention | Q24675326 |
| | Cutaneous wound healing: recruiting developmental pathways for regeneration | Q27004417 |
| | Effects of transplanted mesenchymal stem cells isolated from Wharton's jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation | Q28305878 |
| | Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis | Q30882988 |
| | Overexpression of decorin induces apoptosis and cell growth arrest in cultured rat mesangial cells in vitro | Q33339680 |
| | Stem Cell Therapy: A New Treatment for Burns? | Q33765265 |
| | Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair | Q33987579 |
| | Cellular signaling in tissue regeneration | Q34154956 |
| | Mediators leading to fibrosis - how to measure and control them in tissue engineering. | Q34159587 |
| | Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial | Q34453706 |
| | Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells | Q34694012 |
| | Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis | Q35639618 |
| | Increased Plasminogen Activator Inhibitor-1 in Keloid Fibroblasts May Account for their Elevated Collagen Accumulation in Fibrin Gel Cultures | Q35749077 |
| | Mesenchymal stem cell therapy for attenuation of scar formation during wound healing | Q36084821 |
| | Umbilical cord blood mesenchymal stem cells protect amyloid-β42 neurotoxicity via paracrine | Q36507936 |
| | Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction | Q36861693 |
| | Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations | Q36921222 |
| | Cellular and molecular pathology of HTS: basis for treatment | Q36922428 |
| | Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts | Q36943056 |
| | Concise review: mesenchymal stem cells and translational medicine: emerging issues. | Q37056276 |
| | Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. | Q37257183 |
| | Potential cellular and molecular causes of hypertrophic scar formation. | Q37308688 |
| | Signaling cross-talk between TGF-beta/BMP and other pathways | Q37323342 |
| | TGF-beta and fibrosis in different organs - molecular pathway imprints | Q37524907 |
| | New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity | Q37643715 |
| | Molecular dissection of abnormal wound healing processes resulting in keloid disease. | Q37651177 |
| | PAI-1 in tissue fibrosis | Q37861626 |
| | Epidemiology and impact of scarring after burn injury: a systematic review of the literature | Q37964454 |
| | Mechanisms of action of mesenchymal stem cells in cutaneous wound repair and regeneration | Q37996884 |
| | The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord | Q38066801 |
| | The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation | Q38068755 |
| | Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. | Q38096939 |
| | Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases. | Q38481817 |
| | Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells | Q38499423 |
| | Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells | Q39422857 |
| | Mesenchymal stem cell therapy in skin: why and what for? | Q39430523 |
| | Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells | Q39699030 |
| | The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis | Q39984252 |
| | Prospective controlled trial of safety of human umbilical cord derived-mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis | Q40272001 |
| | Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair | Q40667980 |
| | Hypoxia upregulates VEGF production in keloid fibroblasts. | Q40812522 |
| | The molecular basis of keloid and hypertrophic scar formation | Q40867502 |
| | Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors | Q42456473 |
| | Human mesenchymal stem cells may be involved in keloid pathogenesis | Q43684142 |
| | Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells | Q43709143 |
| | Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts | Q44773194 |
| | Collagen cross-linking by adipose-derived mesenchymal stromal cells and scar-derived mesenchymal cells: Are mesenchymal stromal cells involved in scar formation? | Q45926551 |
| | Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. | Q45946151 |
| | Low decorin expression along with inherent activation of ERK1,2 in ear lobe keloids | Q46096891 |
| | Improved scar quality following primary and secondary healing of cutaneous wounds. | Q51793108 |
| | Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring. | Q53194966 |
| | Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. | Q53307976 |
| | The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. | Q54295264 |
| | Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring | Q83620594 |
| | Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis | Q84047711 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | 299-307 | |
| P577 | publication date | 2014-01-16 | |
| P1433 | published in | Stem Cells Translational Medicine | Q26842216 |
| P1476 | title | Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts | |
| P478 | volume | 3 | |